ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product

By Jon Kamp Of DOW JONES NEWSWIRES C.R. Bard Inc. (BCR) disclosed Tuesday that its Davol Inc. subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair. The medical-device maker said its previously issued guidance for the fourth quarter last year and full-year this year remains unchanged despite the recall. The company disclosed the event in a brief filing with the Securities and Exchange Commission, where it said the recall started on Friday. It did not describe a reason for the recall, and a spokesman could not be reached for immediate comment on the matter. Bard's shares traded up 26 cents to $91.31 early Tuesday. -By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
11/30/201610:30:00Bard to Present at the Citi Healthcare Conference
11/23/201610:30:00Bard to Present at the Piper Jaffray Healthcare Conference
11/22/201614:17:46Current Report Filing (8-k)
11/08/201610:30:00Bard to Present at the Stifel Healthcare Conference
10/31/201616:36:04Statement of Changes in Beneficial Ownership (4)
10/26/201613:12:12Quarterly Report (10-q)
10/25/201616:33:53Current Report Filing (8-k)
10/25/201616:15:00Bard Announces Third Quarter Results
10/21/201609:01:33Current Report Filing (8-k)
10/12/201616:15:00Bard Declares Quarterly Dividend
10/03/201610:30:00Bard to Host Earnings Conference Call on October 25, 2016
09/30/201609:00:00The Medical Device Industry's Focus on Cardio and Cardiovascular...
09/29/201616:16:18Statement of Changes in Beneficial Ownership (4)
09/27/201616:07:29Statement of Changes in Beneficial Ownership (4)
09/22/201608:30:00LUTONIX® Global Real-World Registry 24-Month Outcomes Presented...
09/20/201615:26:04Statement of Changes in Beneficial Ownership (4)
09/19/201617:37:00FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee...
09/08/201609:45:24Statement of Changes in Beneficial Ownership (4)
09/08/201609:44:57Statement of Changes in Beneficial Ownership (4)
09/06/201611:00:00Bard to Present at Morgan Stanley Global Healthcare Conference

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US